Trexquant Investment’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,678
Closed -$617K 1840
2024
Q2
$617K Buy
14,678
+5,978
+69% +$204K 0.01% 1175
2024
Q1
$255K Sell
8,700
-14,347
-62% -$457K 0.01% 1329
2023
Q4
$838K Sell
23,047
-3,576
-13% -$117K 0.02% 885
2023
Q3
$854K Sell
26,623
-16,868
-39% -$573K 0.02% 810
2023
Q2
$1.36M Buy
43,491
+18,308
+73% +$418K 0.04% 649
2023
Q1
$574K Buy
+25,183
New +$649K 0.02% 940
2020
Q4
Sell
-5,468
Closed -$213K 1462
2020
Q3
$213K Buy
+5,468
New +$240K 0.01% 1060
2020
Q1
Sell
-5,442
Closed -$225K 1395
2019
Q4
$225K Buy
+5,442
New +$229K 0.01% 868
2018
Q1
Sell
-8,247
Closed -$231K 1359
2017
Q4
$231K Buy
+8,247
New +$252K 0.03% 867

Other funds holding SRDX

Trexquant Investment's SRDX Position: Q3 2024 in Review

Trexquant Investment sold out of Surmodics (SRDX) in Q3 2024, closing a stake of 14,678 shares — an estimated $617K sold.

Trexquant Investment first reported a position in SRDX in Q4 2017 and held it in 9 quarters. The position peaked at $1.36M in Q2 2023. 126 funds tracked by Wall St. Rank hold SRDX as of Q3 2024.

  • Trexquant Investment reported no remaining Surmodics position as of Q3 2024 after selling out during the quarter.
  • Trexquant Investment sold 14,678 Surmodics shares in Q3 2024, an estimated $617K.
  • Trexquant Investment first reported a position in Surmodics in Q4 2017 and held it in 9 quarters.
  • Trexquant Investment's Surmodics position peaked at $1.36M in Q2 2023.
  • 126 funds tracked by Wall St. Rank held Surmodics as of Q3 2024.

Based on Trexquant Investment's 13F filing for Q3 2024, filed 12 Nov 2024.